The agrin protein, identified in the plasma of lung cancer animal models, has been associated with NSCLC progression through its activation of the phosphatidylinositol 3-kinase/Protein B kinase (PI3K/AKT) signaling pathway. Here, AGRN is linked to non-small cell lung carcinoma.